Agreed. The tech is awesome.
something else holds it back.
It seems a no brainer that every hospital pathology lab of a decent size would have one on it’s want list.
So why isn’t it selling in vast numbers?
Is it too expensive? Probably not for a western hospital .
Is it tested? Yep to the nth degree.
Let’s sell the patent to someone else and get on with doing something we can sell.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-15
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.001(7.14%) |
Mkt cap ! $24.27M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.5¢ | 1.4¢ | $6.003K | 424.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1817935 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1483000 | 5 |
View Market Depth
| Last trade - 15.54pm 21/08/2024 (20 minute delay) ? |
| LBT (ASX) Chart |